Medications for depressive disorders are forecast to account for the largest revenue among mental health medication categories in Brazil in 2024, with a total of 537.77 million U.S. dollars. That year, revenue from anxiety and sleep medications is expected to reach 125.19 million U.S. dollars, while revenue from medications for treating psychotic disorders is estimated at 112.17 million U.S. dollars.
Revenue of the mental health medications market in Brazil 2024, by segment
(in million U.S. dollars)
Data provided by Statista Market Insights are estimates.
Mental health disorders are common illnesses found among people all over the world. These disorders are caused by a variety of genetic and environmental factors that cause imbalances in a person's physical and emotional behavior. Most mental health disorders can be treated with behavioral and psychotherapies. In some cases, however, medication is prescribed along with these treatments. The mental health market represents the market for the drugs that are used to treat various mild to serious mental health disorders. The market is divided into three markets that have been based on the disorders that are being treated. This includes depressive disorders, anxiety and related sleeping disorders, and different types of psychotic disorders.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Pfizer, Bristol-Myers Squibb, Johnson & Johnson, AbbVie, and Sumitomo pharma
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (February 14, 2024). Revenue of the mental health medications market in Brazil 2024, by segment (in million U.S. dollars) [Graph]. In Statista. Retrieved November 04, 2024, from https://www.statista.com/forecasts/1451016/revenue-mental-health-medications-market-by-segment-brazil
Statista. "Revenue of the mental health medications market in Brazil 2024, by segment (in million U.S. dollars)." Chart. February 14, 2024. Statista. Accessed November 04, 2024. https://www.statista.com/forecasts/1451016/revenue-mental-health-medications-market-by-segment-brazil
Statista. (2024). Revenue of the mental health medications market in Brazil 2024, by segment (in million U.S. dollars). Statista. Statista Inc.. Accessed: November 04, 2024. https://www.statista.com/forecasts/1451016/revenue-mental-health-medications-market-by-segment-brazil
Statista. "Revenue of The Mental Health Medications Market in Brazil 2024, by Segment (in Million U.S. Dollars)." Statista, Statista Inc., 14 Feb 2024, https://www.statista.com/forecasts/1451016/revenue-mental-health-medications-market-by-segment-brazil
Statista, Revenue of the mental health medications market in Brazil 2024, by segment (in million U.S. dollars) Statista, https://www.statista.com/forecasts/1451016/revenue-mental-health-medications-market-by-segment-brazil (last visited November 04, 2024)
Revenue of the mental health medications market in Brazil 2024, by segment (in million U.S. dollars) [Graph], Statista, February 14, 2024. [Online]. Available: https://www.statista.com/forecasts/1451016/revenue-mental-health-medications-market-by-segment-brazil
